Global Insulin Pen Market by Product Type (Disposable, Reusable), By Distribution Channel (Online Pharmacies, Hospital Pharmacies, Retail Pharmacies, diabetes Clinics), By Application (Type 1 Diabetes, Type 2 Diabetes), By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa); Trend Analysis, Market Competition Scenario & Outlook, 2016-2026
Published:
April 2020
Report Code:
BWC20010
Available Format:
PDF PDF Icon
Pages:
186

insulin pen market bwc20010

SCOPE           

1.    Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

2.1. Qualitative Research

2.1.1.   Primary & Secondary Sources

2.2. Quantitative Research

2.2.1.   Primary & Secondary Sources

2.3. Breakdown of Primary Research Respondents, By Region

2.3.1.   Secondary Research

2.3.2.   Primary Research

2.4. Breakdown of Primary Research Respondents

2.5. Market Size Estimation

2.6. Assumption for the Study

2.7. Market Breakdown & Data Triangulation

3.    Executive Summary


4.    Global Insulin Pen Industry Insights

4.1. Industry Value Chain Analysis

4.2. DROC Analysis

4.2.1.   Growth Drivers

4.2.2.   Restraints

4.2.3.   Opportunities

4.2.4.   Challenges

4.3. Technological Landscape/Recent Development

4.4. Company Market Share Analysis, 2019

4.5. Porter’s Five Forces Analysis

4.5.1.   Bargaining Power of Suppliers

4.5.2.   Bargaining Power of Buyers

4.5.3.   Threat of New Entrants

4.5.4.   Threat of Substitutes

4.5.5.   Intensity of Rivalry

5.    Global Insulin Pen Market Overview

5.1. Market Size & Forecast by Value, 2016-2026

5.1.1.   By Value (USD Billion)

5.2. Market Share & Forecast

5.2.1.   By Product Type

5.2.1.1.       Disposable

5.2.1.2.       Reusable

5.2.2.   By Distribution Channel

5.2.2.1.       Online Pharmacies

5.2.2.2.       Hospital Pharmacies

5.2.2.3.       Retail Pharmacies

5.2.2.4.       Diabetes Clinics

5.2.3.   By Application

5.2.3.1.       Type 1 Diabetes

5.2.3.2.       Type 2 Diabetes

5.2.4.   By Region

5.2.4.1.   North America

5.2.4.2.   Europe

5.2.4.3.   Asia Pacific

5.2.4.4.   Latin America

5.2.4.5.   Middle East & Africa

6.    North America Insulin Pen Market

6.1. Market Size & Forecast by Value, 2016-2026

6.1.1.   By Value (USD Billion)

6.2. Market Share & Forecast

6.2.1.   By Product Type

6.2.2.   By Distribution Channel

6.2.3.   By Application

6.2.4.   By Country

6.2.4.1.     United States

6.2.4.2.     Canada

7.    Europe Insulin Pen Market

7.1. Market Size & Forecast by Value, 2016-2026

7.1.1.   By Value (USD Billion)

7.2. Market Share & Forecast

7.2.1.   By Product Type

7.2.2.   By Distribution Channel

7.2.3.   By Application

7.2.4.   By Country

7.2.4.1.     Germany

7.2.4.2.     United Kingdom

7.2.4.3.     France

7.2.4.4.     Italy

7.2.4.5.     Spain

7.2.4.6.     Rest of Europe

8.    Asia Pacific Insulin Pen Market

8.1. Market Size & Forecast by Value, 2016-2026

8.1.1.   By Value (USD Billion)

8.2. Market Share & Forecast

8.2.1.   By Product Type

8.2.2.   By Distribution Channel

8.2.3.   By Application

8.2.4.   By Country

8.2.4.1.     China

8.2.4.2.     India

8.2.4.3.     Japan

8.2.4.4.     Rest of Asia Pacific

9.    Latin America Insulin Pen Market

9.1. Market Size & Forecast by Value, 2016-2026

9.1.1.   By Value (USD Billion)

9.2. Market Share & Forecast

9.2.1.   By Product Type

9.2.2.   By Distribution Channel

9.2.3.   By Application

9.2.4.   By Country

9.2.4.1.     Brazil

9.2.4.2.     Mexico

9.2.4.3.     Argentina

9.2.4.4.     Rest of Latin America

10.Middle East & Africa Insulin Pen Market

10.1. Market Size & Forecast by Value, 2016-2026

10.1.1.    By Value (USD Billion)

10.2. Market Share & Forecast

10.2.1.  By Product Type

10.2.2.  By Distribution Channel

10.2.3.  By Application

10.2.4.  By Country

10.2.4.1.      Saudi Arabia

10.2.4.2.      UAE

10.2.4.3.      South Africa

10.2.4.4.      Rest of Middle East & Africa

11.Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *

11.1.           B. Braun Melsungen AG

11.2.           Eli Lilly and Company

11.3.           Artsana S.p.A.

11.4.           Novo Nordisk A/S

11.5.           Owen Mumford Ltd.

11.6.           TERUMO CORPORATION

11.7.           HTL-Strefa

11.8.           Companion Medical

11.9.           Berlin-Chemie Ag

11.10.        Pendiq Gmbh

11.11.        Emperra GmbH E-Health Technologies

11.12.        Ypsomed Ag

11.13.        Sanofi

11.14.        Digital Medics

11.15.        Diamesco

11.16.        Gerresheimer AG

11.17.        Companion Medical

11.18.        Biocon

11.19.        Jiangsu Delfu medical device Co.

11.20.        Lantus

11.21.        Other prominent players

* Financial details in case of unlisted companies will be available as per data availability

**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable

 

WHY CHOOSE US

  • 24/7 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Coustom Research Service

    Ask the Analyst to customize an exclusive study to serve your research needs.

  • Quality & Accuracy

    offers best quality reports based on various authentic and accurate data findings.

  • Data Visualization

    As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization

  • Information security

    We never share your personal and confidential information. Your personal information is safe and secure with us.